Published in Hepatology on March 12, 1984
Osteoporosis and skeletal fractures in chronic liver disease. Gut (1990) 1.40
Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol (2005) 1.37
Primary biliary cirrhosis and osteoporosis: a case-control study. J Bone Miner Metab (2008) 1.05
Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut (1988) 1.05
Long term prognosis for babies with neonatal liver disease. Arch Dis Child (1985) 1.04
Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut (1986) 1.02
The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int (2003) 0.96
Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications. World J Gastroenterol (2014) 0.90
Osteoporosis in primary biliary cirrhosis of the liver. Prz Gastroenterol (2014) 0.80
Occurrence of autoimmune hepatitis during the course of primary biliary cirrhosis: report of two cases. Dig Dis Sci (2006) 0.79
The role of serum cytokines in the pathogenesis of hepatic osteodystrophy in male cirrhotic patients. Gastroenterol Res Pract (2012) 0.78
Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin. Dig Dis Sci (2006) 0.78
Diagnosis and Management of Cirrhosis-Related Osteoporosis. Biomed Res Int (2016) 0.75
Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med (1989) 4.07
Cardiac atrophy after bed rest and spaceflight. J Appl Physiol (1985) (2001) 3.04
Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet (1971) 2.64
Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology (1971) 1.88
Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab (1988) 1.87
Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. J Biol Chem (1996) 1.80
Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med (1995) 1.75
Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol (1993) 1.73
A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med (1975) 1.71
Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol (1997) 1.67
Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med (1984) 1.67
Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol (1999) 1.63
Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation. J Urol (1995) 1.60
Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma. J Clin Endocrinol Metab (1968) 1.55
Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients. Medicine (Baltimore) (1969) 1.55
Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite. J Clin Invest (1969) 1.54
Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med (1980) 1.50
The effect of calcium citrate on bone density in the early and mid-postmenopausal period: a randomized placebo-controlled study. Am J Ther (1999) 1.49
Factors related to the resolution of treated hand infections. J Hand Surg Am (1982) 1.48
Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. J Vet Intern Med (2010) 1.45
Assay of urinary oxalate: six methodologies compared. Clin Chem (1983) 1.44
The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. J Clin Invest (1974) 1.43
A further study of oxalate bioavailability in foods. J Urol (1990) 1.43
A direct assessment of the importance of conjugation for biliary transport of sulfobromophthalein sodium. J Lab Clin Med (1970) 1.40
The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest (1977) 1.37
The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab (1982) 1.36
Regulation of hepatic 7 alpha-hydroxylase expression and response to dietary cholesterol in the rat and hamster. J Biol Chem (1995) 1.33
Depression of lymphocyte reactivity to phytohemagglutinin by serum from patients with liver disease. Cell Immunol (1973) 1.31
The potential role of salt abuse on the risk for kidney stone formation. J Urol (1993) 1.31
Normocalcemic primary hyperparathyroidism. Am J Med (1969) 1.30
The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res (1998) 1.29
DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE. J Clin Invest (1961) 1.27
Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate. J Clin Invest (1977) 1.23
Low urinary citrate excretion in nephrolithiasis. Urology (1983) 1.22
Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int (1983) 1.20
Metabolic effects of parathyroidectomy in asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab (1976) 1.20
Adenovirus-mediated transfer of a gene encoding cholesterol 7 alpha-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J Clin Invest (1995) 1.18
Serum gamma-glutamyl transpeptidase activity in viral hepatitis: suppression in pregnancy and by birth control pills. Gastroenterology (1977) 1.17
Effect of orange juice consumption on urinary stone risk factors. J Urol (1993) 1.16
A controlled trial of steroid therapy in massive hepatic necrosis. Am J Gastroenterol (1974) 1.16
Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res (1992) 1.15
Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. N Engl J Med (1972) 1.15
The current role of medical treatment of nephrolithiasis: the impact of improved techniques of stone removal. J Urol (1985) 1.15
Spontaneous precipitation of brushite in urine: evidence that brushite is the nidus of renal stones originating as calcium phosphate. Proc Natl Acad Sci U S A (1971) 1.15
Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate. N Engl J Med (1974) 1.14
Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease. Kidney Int (1992) 1.14
Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol (1995) 1.13
Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int (1986) 1.12
Hydrochlorothiazide therapy in nephrolithiasis. Effect on the urinary activity product and formation product of brushite. Clin Pharmacol Ther (1973) 1.11
Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch Intern Med (1986) 1.11
Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol (1985) 1.11
Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes. N Engl J Med (1986) 1.10
Sustained reduction in urinary calcium during long-term treatment with slow release neutral potassium phosphate in absorptive hypercalciuria. J Urol (1998) 1.10
Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab (1999) 1.10
Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. Hepatology (1990) 1.10
Should patients with single renal stone occurrence undergo diagnostic evaluation? J Urol (1982) 1.08
Spectrophotometric assay of the liver enzyme that catalyzes sulfobromophthalein-glutathione conjugation. J Lab Clin Med (1966) 1.08
Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest (1981) 1.08
Absence of circulating interferon in patients with infectious and serum hepatitis. Proc Soc Exp Biol Med (1968) 1.07
Gastrointestinal calcium absorption in nephrolithiasis. J Clin Endocrinol Metab (1972) 1.07
Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol (1986) 1.06
Rapid enhancement of chick intestinal DNA-dependent RNA polymerase II activity by 1 alpha, 25-dihydroxyvitamin D3, in vivo. Proc Natl Acad Sci U S A (1974) 1.06
Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med (1975) 1.06
Intrahepatic cholestasis due to therapy of rheumatoid arthritis. Gastroenterology (1973) 1.04
Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res (1995) 1.04
Hepatitis and pregnancy. J Pediatr (1977) 1.04
An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab (1979) 1.04
Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate. Ann Intern Med (1986) 1.03
The treatment of osteoporosis with calcium infusions. Clinical studies. Am J Med (1969) 1.03
Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol. J Clin Invest (1976) 1.03
Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol (1985) 1.03
Increased intestinal chromatin template activity. Influence of 1alpha,25-dihydroxyvitamin D3 and hormone-receptor complexes. J Biol Chem (1976) 1.02
Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Mol Endocrinol (1996) 1.02
Biochemical changes associated with the symptomatic human intervertebral disk. Clin Orthop Relat Res (1993) 1.02
Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res (2000) 1.01
Psoriatic lesions induced by antitumour necrosis factor-alpha treatment: two cases. Br J Dermatol (2004) 1.01
Reduced bone formation and relatively increased bone resorption in absorptive hypercalciuria. Kidney Int (2007) 1.01
The hypercalciuria of diabetes mellitus: its amelioration with insulin. Clin Endocrinol (Oxf) (1978) 1.00
Thiazide diuretics and calcium metabolism. Metabolism (1973) 0.99
HeLaTG cells have mitochondrial DNA inserted into the c-myc oncogene. Oncogene (1991) 0.99
Impaired adaptation to salt-induced urinary calcium losses in postmenopausal osteoporosis. Trans Assoc Am Physicians (1985) 0.99
Dietary fatty acids regulate hepatic low density lipoprotein (LDL) transport by altering LDL receptor protein and mRNA levels. J Clin Invest (1993) 0.99
Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab (1989) 0.99
Preferential infiltration of macrophages during early stages of insulitis in diabetes-prone BB rats. Diabetes (1988) 0.98
Relationship of estrogen and pregnancy to calcium homeostasis in pseudohypoparathyroidism. J Clin Endocrinol Metab (1986) 0.98
Low serum alkaline phosphatase activity in Wilson's disease. Hepatology (1986) 0.98
Hyperemesis gravidarum. I. Evidence of hepatic dysfunction. Obstet Gynecol (1968) 0.98
Expression of aromatase in the human growth plate. J Mol Endocrinol (2001) 0.97
Sequential changes in bone density before and after parathyroidectomy in primary hyperparathyroidism. Invest Radiol (1983) 0.97
Nucleation and growth of brushite and calcium oxalate in urine of stone-formers. Metabolism (1976) 0.96
The effect of polypeptide hormones on lipid monolayers. ii. The effect of insulin analogues, vasopressin, oxytocin, thyrocalcitonin, adrenocorticotropin, and 3',5'-cyclic AMP on the uptake of Ca2+ by monomolecular films of monooctadecyl phosphate. Biochim Biophys Acta (1969) 0.96
Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr (1990) 0.96
Overexpression of cholesterol 7alpha-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced. J Biol Chem (1998) 0.96